nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Gemcitabine—lung cancer	0.407	1	CrCtD
Zalcitabine—Lamivudine—Gemcitabine—lung cancer	0.119	0.558	CrCrCtD
Zalcitabine—SLC29A1—Pemetrexed—lung cancer	0.0629	0.224	CbGbCtD
Zalcitabine—DCK—Pemetrexed—lung cancer	0.0583	0.207	CbGbCtD
Zalcitabine—Cytarabine—Gemcitabine—lung cancer	0.0496	0.232	CrCrCtD
Zalcitabine—Decitabine—Gemcitabine—lung cancer	0.0449	0.21	CrCrCtD
Zalcitabine—SLC29A2—Gemcitabine—lung cancer	0.0394	0.14	CbGbCtD
Zalcitabine—SLC29A1—Gemcitabine—lung cancer	0.0226	0.0806	CbGbCtD
Zalcitabine—DCK—Gemcitabine—lung cancer	0.021	0.0746	CbGbCtD
Zalcitabine—SLC22A7—Docetaxel—lung cancer	0.00556	0.0198	CbGbCtD
Zalcitabine—CYP3A5—Gefitinib—lung cancer	0.00413	0.0147	CbGbCtD
Zalcitabine—SLC22A7—Methotrexate—lung cancer	0.00401	0.0143	CbGbCtD
Zalcitabine—CYP3A5—Teniposide—lung cancer	0.00401	0.0143	CbGbCtD
Zalcitabine—CYP3A7—Paclitaxel—lung cancer	0.00298	0.0106	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00298	0.0106	CbGbCtD
Zalcitabine—CYP3A7—Irinotecan—lung cancer	0.00294	0.0105	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00294	0.0105	CbGbCtD
Zalcitabine—CYP2C9—Gefitinib—lung cancer	0.00277	0.00986	CbGbCtD
Zalcitabine—CYP2C9—Teniposide—lung cancer	0.00269	0.00956	CbGbCtD
Zalcitabine—CYP2D6—Gefitinib—lung cancer	0.00254	0.00902	CbGbCtD
Zalcitabine—CYP3A5—Crizotinib—lung cancer	0.00253	0.00901	CbGbCtD
Zalcitabine—CYP3A5—Erlotinib—lung cancer	0.00244	0.00869	CbGbCtD
Zalcitabine—CYP3A5—Paclitaxel—lung cancer	0.00224	0.00796	CbGbCtD
Zalcitabine—CYP3A5—Irinotecan—lung cancer	0.00221	0.00785	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00216	0.00767	CbGbCtD
Zalcitabine—CYP3A7—Docetaxel—lung cancer	0.00216	0.00767	CbGbCtD
Zalcitabine—CYP2D6—Vinorelbine—lung cancer	0.00195	0.00695	CbGbCtD
Zalcitabine—CYP3A5—Etoposide—lung cancer	0.00177	0.00629	CbGbCtD
Zalcitabine—CYP3A4—Topotecan—lung cancer	0.00176	0.00627	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—lung cancer	0.00171	0.00607	CbGbCtD
Zalcitabine—CYP3A5—Docetaxel—lung cancer	0.00162	0.00575	CbGbCtD
Zalcitabine—CYP3A4—Gefitinib—lung cancer	0.00161	0.00573	CbGbCtD
Zalcitabine—CYP3A4—Teniposide—lung cancer	0.00156	0.00556	CbGbCtD
Zalcitabine—CYP2C9—Paclitaxel—lung cancer	0.0015	0.00534	CbGbCtD
Zalcitabine—CYP2D6—Erlotinib—lung cancer	0.0015	0.00533	CbGbCtD
Zalcitabine—CYP3A4—Vinorelbine—lung cancer	0.00124	0.00442	CbGbCtD
Zalcitabine—CYP2C9—Cisplatin—lung cancer	0.00121	0.00429	CbGbCtD
Zalcitabine—CYP2D6—Vinblastine—lung cancer	0.0012	0.00428	CbGbCtD
Zalcitabine—CYP3A4—Crizotinib—lung cancer	0.000988	0.00351	CbGbCtD
Zalcitabine—CYP3A4—Erlotinib—lung cancer	0.000953	0.00339	CbGbCtD
Zalcitabine—CYP3A4—Paclitaxel—lung cancer	0.000873	0.0031	CbGbCtD
Zalcitabine—CYP3A4—Irinotecan—lung cancer	0.000861	0.00306	CbGbCtD
Zalcitabine—CYP3A4—Vinblastine—lung cancer	0.000765	0.00272	CbGbCtD
Zalcitabine—CYP2D6—Doxorubicin—lung cancer	0.00074	0.00263	CbGbCtD
Zalcitabine—CYP3A4—Etoposide—lung cancer	0.000689	0.00245	CbGbCtD
Zalcitabine—DCK—Topotecan—Irinotecan—lung cancer	0.000687	0.821	CbGdCrCtD
Zalcitabine—CYP3A4—Docetaxel—lung cancer	0.000631	0.00224	CbGbCtD
Zalcitabine—Gemcitabine—RRM1—lung cancer	0.000624	0.429	CrCbGaD
Zalcitabine—CYP3A4—Doxorubicin—lung cancer	0.00047	0.00167	CbGbCtD
Zalcitabine—Lamivudine—ABCC3—lung cancer	0.000298	0.205	CrCbGaD
Zalcitabine—Gemcitabine—TYMS—lung cancer	0.000262	0.18	CrCbGaD
Zalcitabine—DCK—Epirubicin—Doxorubicin—lung cancer	0.000149	0.179	CbGdCrCtD
Zalcitabine—Lamivudine—ABCG2—lung cancer	0.000145	0.0996	CrCbGaD
Zalcitabine—SLC29A1—mammary gland—lung cancer	0.000116	0.112	CbGeAlD
Zalcitabine—SLC29A2—cardiac atrium—lung cancer	0.000108	0.104	CbGeAlD
Zalcitabine—SLC29A1—respiratory system—lung cancer	7.72e-05	0.0745	CbGeAlD
Zalcitabine—Gemcitabine—ABCB1—lung cancer	6.63e-05	0.0455	CrCbGaD
Zalcitabine—SLC29A1—bronchus—lung cancer	6.35e-05	0.0613	CbGeAlD
Zalcitabine—DCK—bronchus—lung cancer	6.07e-05	0.0585	CbGeAlD
Zalcitabine—Lamivudine—ABCB1—lung cancer	6.03e-05	0.0414	CrCbGaD
Zalcitabine—SLC29A1—trachea—lung cancer	5.71e-05	0.055	CbGeAlD
Zalcitabine—SLC29A2—lymph node—lung cancer	5.65e-05	0.0545	CbGeAlD
Zalcitabine—CYP2C9—mammary gland—lung cancer	5.64e-05	0.0544	CbGeAlD
Zalcitabine—DCK—trachea—lung cancer	5.45e-05	0.0526	CbGeAlD
Zalcitabine—SLC29A1—cardiac atrium—lung cancer	5.36e-05	0.0517	CbGeAlD
Zalcitabine—DCK—cardiac atrium—lung cancer	5.12e-05	0.0494	CbGeAlD
Zalcitabine—SLC29A1—bone marrow—lung cancer	4.52e-05	0.0436	CbGeAlD
Zalcitabine—DCK—bone marrow—lung cancer	4.32e-05	0.0417	CbGeAlD
Zalcitabine—SLC29A1—lung—lung cancer	4.1e-05	0.0395	CbGeAlD
Zalcitabine—DCK—lung—lung cancer	3.92e-05	0.0378	CbGeAlD
Zalcitabine—CYP3A5—respiratory system—lung cancer	3.82e-05	0.0368	CbGeAlD
Zalcitabine—SLC29A1—lymph node—lung cancer	2.8e-05	0.027	CbGeAlD
Zalcitabine—DCK—lymph node—lung cancer	2.68e-05	0.0258	CbGeAlD
Zalcitabine—Tachycardia—Paclitaxel—lung cancer	2.14e-05	0.00033	CcSEcCtD
Zalcitabine—Anorexia—Etoposide—lung cancer	2.13e-05	0.000329	CcSEcCtD
Zalcitabine—Skin disorder—Paclitaxel—lung cancer	2.13e-05	0.000329	CcSEcCtD
Zalcitabine—Abdominal pain—Irinotecan—lung cancer	2.13e-05	0.000328	CcSEcCtD
Zalcitabine—Body temperature increased—Irinotecan—lung cancer	2.13e-05	0.000328	CcSEcCtD
Zalcitabine—Decreased appetite—Cisplatin—lung cancer	2.12e-05	0.000327	CcSEcCtD
Zalcitabine—Hyperhidrosis—Paclitaxel—lung cancer	2.12e-05	0.000327	CcSEcCtD
Zalcitabine—Nasopharyngitis—Doxorubicin—lung cancer	2.11e-05	0.000326	CcSEcCtD
Zalcitabine—Anaemia—Docetaxel—lung cancer	2.11e-05	0.000325	CcSEcCtD
Zalcitabine—Depression—Methotrexate—lung cancer	2.1e-05	0.000323	CcSEcCtD
Zalcitabine—Anorexia—Paclitaxel—lung cancer	2.09e-05	0.000323	CcSEcCtD
Zalcitabine—Gastritis—Doxorubicin—lung cancer	2.09e-05	0.000322	CcSEcCtD
Zalcitabine—Pain—Cisplatin—lung cancer	2.09e-05	0.000322	CcSEcCtD
Zalcitabine—Muscular weakness—Doxorubicin—lung cancer	2.08e-05	0.000321	CcSEcCtD
Zalcitabine—Vomiting—Vinorelbine—lung cancer	2.07e-05	0.00032	CcSEcCtD
Zalcitabine—Body temperature increased—Gemcitabine—lung cancer	2.07e-05	0.000319	CcSEcCtD
Zalcitabine—Rash—Vinorelbine—lung cancer	2.06e-05	0.000317	CcSEcCtD
Zalcitabine—Dermatitis—Vinorelbine—lung cancer	2.05e-05	0.000317	CcSEcCtD
Zalcitabine—Abdominal distension—Doxorubicin—lung cancer	2.05e-05	0.000317	CcSEcCtD
Zalcitabine—Headache—Vinorelbine—lung cancer	2.04e-05	0.000315	CcSEcCtD
Zalcitabine—Syncope—Docetaxel—lung cancer	2.04e-05	0.000315	CcSEcCtD
Zalcitabine—Dysphagia—Doxorubicin—lung cancer	2.04e-05	0.000315	CcSEcCtD
Zalcitabine—Leukopenia—Docetaxel—lung cancer	2.04e-05	0.000315	CcSEcCtD
Zalcitabine—CYP3A5—lung—lung cancer	2.03e-05	0.0196	CbGeAlD
Zalcitabine—Eosinophilia—Doxorubicin—lung cancer	2.02e-05	0.000312	CcSEcCtD
Zalcitabine—Palpitations—Docetaxel—lung cancer	2.01e-05	0.000311	CcSEcCtD
Zalcitabine—Feeling abnormal—Cisplatin—lung cancer	2.01e-05	0.00031	CcSEcCtD
Zalcitabine—Loss of consciousness—Docetaxel—lung cancer	2e-05	0.000309	CcSEcCtD
Zalcitabine—Pancreatitis—Doxorubicin—lung cancer	2e-05	0.000309	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Paclitaxel—lung cancer	2e-05	0.000308	CcSEcCtD
Zalcitabine—Dyspnoea—Etoposide—lung cancer	1.99e-05	0.000308	CcSEcCtD
Zalcitabine—Somnolence—Etoposide—lung cancer	1.99e-05	0.000307	CcSEcCtD
Zalcitabine—Cough—Docetaxel—lung cancer	1.99e-05	0.000307	CcSEcCtD
Zalcitabine—Insomnia—Paclitaxel—lung cancer	1.98e-05	0.000306	CcSEcCtD
Zalcitabine—Epistaxis—Methotrexate—lung cancer	1.98e-05	0.000306	CcSEcCtD
Zalcitabine—Hypersensitivity—Irinotecan—lung cancer	1.98e-05	0.000306	CcSEcCtD
Zalcitabine—Convulsion—Docetaxel—lung cancer	1.97e-05	0.000304	CcSEcCtD
Zalcitabine—Hypertension—Docetaxel—lung cancer	1.97e-05	0.000303	CcSEcCtD
Zalcitabine—Dyspnoea—Paclitaxel—lung cancer	1.96e-05	0.000302	CcSEcCtD
Zalcitabine—Somnolence—Paclitaxel—lung cancer	1.95e-05	0.000301	CcSEcCtD
Zalcitabine—Decreased appetite—Etoposide—lung cancer	1.95e-05	0.0003	CcSEcCtD
Zalcitabine—Myalgia—Docetaxel—lung cancer	1.94e-05	0.000299	CcSEcCtD
Zalcitabine—Arthralgia—Docetaxel—lung cancer	1.94e-05	0.000299	CcSEcCtD
Zalcitabine—Dyspepsia—Paclitaxel—lung cancer	1.93e-05	0.000298	CcSEcCtD
Zalcitabine—Body temperature increased—Cisplatin—lung cancer	1.93e-05	0.000298	CcSEcCtD
Zalcitabine—Asthenia—Irinotecan—lung cancer	1.93e-05	0.000298	CcSEcCtD
Zalcitabine—Fatigue—Etoposide—lung cancer	1.93e-05	0.000298	CcSEcCtD
Zalcitabine—Pain—Etoposide—lung cancer	1.91e-05	0.000295	CcSEcCtD
Zalcitabine—Neutropenia—Doxorubicin—lung cancer	1.91e-05	0.000294	CcSEcCtD
Zalcitabine—Dysuria—Doxorubicin—lung cancer	1.91e-05	0.000294	CcSEcCtD
Zalcitabine—Decreased appetite—Paclitaxel—lung cancer	1.91e-05	0.000294	CcSEcCtD
Zalcitabine—Dry mouth—Docetaxel—lung cancer	1.9e-05	0.000293	CcSEcCtD
Zalcitabine—Fatigue—Paclitaxel—lung cancer	1.89e-05	0.000292	CcSEcCtD
Zalcitabine—Hepatitis—Methotrexate—lung cancer	1.89e-05	0.000291	CcSEcCtD
Zalcitabine—Pollakiuria—Doxorubicin—lung cancer	1.89e-05	0.000291	CcSEcCtD
Zalcitabine—Asthenia—Gemcitabine—lung cancer	1.88e-05	0.00029	CcSEcCtD
Zalcitabine—Pain—Paclitaxel—lung cancer	1.88e-05	0.000289	CcSEcCtD
Zalcitabine—Confusional state—Docetaxel—lung cancer	1.87e-05	0.000289	CcSEcCtD
Zalcitabine—Pharyngitis—Methotrexate—lung cancer	1.87e-05	0.000289	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Doxorubicin—lung cancer	1.86e-05	0.000287	CcSEcCtD
Zalcitabine—Oedema—Docetaxel—lung cancer	1.86e-05	0.000287	CcSEcCtD
Zalcitabine—Pruritus—Gemcitabine—lung cancer	1.85e-05	0.000286	CcSEcCtD
Zalcitabine—Infection—Docetaxel—lung cancer	1.85e-05	0.000285	CcSEcCtD
Zalcitabine—Weight decreased—Doxorubicin—lung cancer	1.85e-05	0.000285	CcSEcCtD
Zalcitabine—Feeling abnormal—Etoposide—lung cancer	1.84e-05	0.000284	CcSEcCtD
Zalcitabine—Hyperglycaemia—Doxorubicin—lung cancer	1.84e-05	0.000284	CcSEcCtD
Zalcitabine—Diarrhoea—Irinotecan—lung cancer	1.84e-05	0.000284	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Etoposide—lung cancer	1.83e-05	0.000282	CcSEcCtD
Zalcitabine—Shock—Docetaxel—lung cancer	1.83e-05	0.000282	CcSEcCtD
Zalcitabine—Thrombocytopenia—Docetaxel—lung cancer	1.82e-05	0.000281	CcSEcCtD
Zalcitabine—Visual impairment—Methotrexate—lung cancer	1.82e-05	0.00028	CcSEcCtD
Zalcitabine—Tachycardia—Docetaxel—lung cancer	1.81e-05	0.00028	CcSEcCtD
Zalcitabine—Feeling abnormal—Paclitaxel—lung cancer	1.81e-05	0.000279	CcSEcCtD
Zalcitabine—Skin disorder—Docetaxel—lung cancer	1.81e-05	0.000279	CcSEcCtD
Zalcitabine—Hypersensitivity—Cisplatin—lung cancer	1.8e-05	0.000278	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Paclitaxel—lung cancer	1.79e-05	0.000277	CcSEcCtD
Zalcitabine—Diarrhoea—Gemcitabine—lung cancer	1.79e-05	0.000277	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Doxorubicin—lung cancer	1.78e-05	0.000275	CcSEcCtD
Zalcitabine—Dizziness—Irinotecan—lung cancer	1.78e-05	0.000274	CcSEcCtD
Zalcitabine—Urticaria—Etoposide—lung cancer	1.78e-05	0.000274	CcSEcCtD
Zalcitabine—Jaundice—Doxorubicin—lung cancer	1.77e-05	0.000274	CcSEcCtD
Zalcitabine—Anorexia—Docetaxel—lung cancer	1.77e-05	0.000273	CcSEcCtD
Zalcitabine—Abdominal pain—Etoposide—lung cancer	1.77e-05	0.000273	CcSEcCtD
Zalcitabine—Body temperature increased—Etoposide—lung cancer	1.77e-05	0.000273	CcSEcCtD
Zalcitabine—Eye disorder—Methotrexate—lung cancer	1.76e-05	0.000272	CcSEcCtD
Zalcitabine—Tinnitus—Methotrexate—lung cancer	1.76e-05	0.000271	CcSEcCtD
Zalcitabine—Asthenia—Cisplatin—lung cancer	1.75e-05	0.00027	CcSEcCtD
Zalcitabine—Urticaria—Paclitaxel—lung cancer	1.74e-05	0.000269	CcSEcCtD
Zalcitabine—Body temperature increased—Paclitaxel—lung cancer	1.73e-05	0.000267	CcSEcCtD
Zalcitabine—Abdominal pain—Paclitaxel—lung cancer	1.73e-05	0.000267	CcSEcCtD
Zalcitabine—Epistaxis—Doxorubicin—lung cancer	1.72e-05	0.000265	CcSEcCtD
Zalcitabine—Vomiting—Irinotecan—lung cancer	1.71e-05	0.000264	CcSEcCtD
Zalcitabine—Sinusitis—Doxorubicin—lung cancer	1.71e-05	0.000263	CcSEcCtD
Zalcitabine—Rash—Irinotecan—lung cancer	1.7e-05	0.000262	CcSEcCtD
Zalcitabine—Dermatitis—Irinotecan—lung cancer	1.69e-05	0.000261	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Docetaxel—lung cancer	1.69e-05	0.000261	CcSEcCtD
Zalcitabine—Chills—Methotrexate—lung cancer	1.69e-05	0.000261	CcSEcCtD
Zalcitabine—Headache—Irinotecan—lung cancer	1.69e-05	0.00026	CcSEcCtD
Zalcitabine—Insomnia—Docetaxel—lung cancer	1.68e-05	0.000259	CcSEcCtD
Zalcitabine—Diarrhoea—Cisplatin—lung cancer	1.67e-05	0.000258	CcSEcCtD
Zalcitabine—Alopecia—Methotrexate—lung cancer	1.67e-05	0.000257	CcSEcCtD
Zalcitabine—Vomiting—Gemcitabine—lung cancer	1.67e-05	0.000257	CcSEcCtD
Zalcitabine—Dyspnoea—Docetaxel—lung cancer	1.66e-05	0.000256	CcSEcCtD
Zalcitabine—Somnolence—Docetaxel—lung cancer	1.65e-05	0.000255	CcSEcCtD
Zalcitabine—Rash—Gemcitabine—lung cancer	1.65e-05	0.000255	CcSEcCtD
Zalcitabine—Dermatitis—Gemcitabine—lung cancer	1.65e-05	0.000255	CcSEcCtD
Zalcitabine—Hypersensitivity—Etoposide—lung cancer	1.65e-05	0.000254	CcSEcCtD
Zalcitabine—Headache—Gemcitabine—lung cancer	1.64e-05	0.000253	CcSEcCtD
Zalcitabine—Rhinitis—Doxorubicin—lung cancer	1.64e-05	0.000253	CcSEcCtD
Zalcitabine—Dyspepsia—Docetaxel—lung cancer	1.64e-05	0.000252	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—lung cancer	1.63e-05	0.000252	CcSEcCtD
Zalcitabine—Pharyngitis—Doxorubicin—lung cancer	1.62e-05	0.00025	CcSEcCtD
Zalcitabine—Decreased appetite—Docetaxel—lung cancer	1.62e-05	0.000249	CcSEcCtD
Zalcitabine—Hypersensitivity—Paclitaxel—lung cancer	1.62e-05	0.000249	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—lung cancer	1.61e-05	0.000248	CcSEcCtD
Zalcitabine—Asthenia—Etoposide—lung cancer	1.61e-05	0.000248	CcSEcCtD
Zalcitabine—Fatigue—Docetaxel—lung cancer	1.6e-05	0.000247	CcSEcCtD
Zalcitabine—Pain—Docetaxel—lung cancer	1.59e-05	0.000245	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—lung cancer	1.59e-05	0.000245	CcSEcCtD
Zalcitabine—Pruritus—Etoposide—lung cancer	1.58e-05	0.000244	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—lung cancer	1.57e-05	0.000243	CcSEcCtD
Zalcitabine—Asthenia—Paclitaxel—lung cancer	1.57e-05	0.000243	CcSEcCtD
Zalcitabine—Vomiting—Cisplatin—lung cancer	1.55e-05	0.000239	CcSEcCtD
Zalcitabine—Pruritus—Paclitaxel—lung cancer	1.55e-05	0.000239	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—lung cancer	1.55e-05	0.000239	CcSEcCtD
Zalcitabine—Rash—Cisplatin—lung cancer	1.54e-05	0.000238	CcSEcCtD
Zalcitabine—Dermatitis—Cisplatin—lung cancer	1.54e-05	0.000237	CcSEcCtD
Zalcitabine—Feeling abnormal—Docetaxel—lung cancer	1.53e-05	0.000236	CcSEcCtD
Zalcitabine—Diarrhoea—Etoposide—lung cancer	1.53e-05	0.000236	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—lung cancer	1.53e-05	0.000235	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—lung cancer	1.52e-05	0.000235	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—lung cancer	1.52e-05	0.000235	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Docetaxel—lung cancer	1.52e-05	0.000235	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—lung cancer	1.52e-05	0.000234	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—lung cancer	1.52e-05	0.000234	CcSEcCtD
Zalcitabine—Diarrhoea—Paclitaxel—lung cancer	1.5e-05	0.000232	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—lung cancer	1.48e-05	0.000228	CcSEcCtD
Zalcitabine—Dizziness—Etoposide—lung cancer	1.48e-05	0.000228	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—lung cancer	1.48e-05	0.000228	CcSEcCtD
Zalcitabine—Abdominal pain—Docetaxel—lung cancer	1.47e-05	0.000227	CcSEcCtD
Zalcitabine—Body temperature increased—Docetaxel—lung cancer	1.47e-05	0.000227	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—lung cancer	1.47e-05	0.000227	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—lung cancer	1.47e-05	0.000226	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—lung cancer	1.46e-05	0.000225	CcSEcCtD
Zalcitabine—Dizziness—Paclitaxel—lung cancer	1.45e-05	0.000224	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—lung cancer	1.44e-05	0.000223	CcSEcCtD
Zalcitabine—Cough—Methotrexate—lung cancer	1.43e-05	0.000221	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—lung cancer	1.42e-05	0.000219	CcSEcCtD
Zalcitabine—Vomiting—Etoposide—lung cancer	1.42e-05	0.000219	CcSEcCtD
Zalcitabine—Rash—Etoposide—lung cancer	1.41e-05	0.000218	CcSEcCtD
Zalcitabine—Dermatitis—Etoposide—lung cancer	1.41e-05	0.000217	CcSEcCtD
Zalcitabine—Headache—Etoposide—lung cancer	1.4e-05	0.000216	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—lung cancer	1.4e-05	0.000216	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—lung cancer	1.4e-05	0.000216	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—lung cancer	1.4e-05	0.000216	CcSEcCtD
Zalcitabine—Tension—Doxorubicin—lung cancer	1.4e-05	0.000215	CcSEcCtD
Zalcitabine—Vomiting—Paclitaxel—lung cancer	1.39e-05	0.000215	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—lung cancer	1.39e-05	0.000215	CcSEcCtD
Zalcitabine—Rash—Paclitaxel—lung cancer	1.38e-05	0.000213	CcSEcCtD
Zalcitabine—Dermatitis—Paclitaxel—lung cancer	1.38e-05	0.000213	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—lung cancer	1.38e-05	0.000213	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—lung cancer	1.38e-05	0.000213	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—lung cancer	1.38e-05	0.000212	CcSEcCtD
Zalcitabine—Headache—Paclitaxel—lung cancer	1.37e-05	0.000212	CcSEcCtD
Zalcitabine—Hypersensitivity—Docetaxel—lung cancer	1.37e-05	0.000211	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—lung cancer	1.37e-05	0.000211	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—lung cancer	1.35e-05	0.000208	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—lung cancer	1.34e-05	0.000207	CcSEcCtD
Zalcitabine—Asthenia—Docetaxel—lung cancer	1.33e-05	0.000206	CcSEcCtD
Zalcitabine—Infection—Methotrexate—lung cancer	1.33e-05	0.000205	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—lung cancer	1.32e-05	0.000203	CcSEcCtD
Zalcitabine—Pruritus—Docetaxel—lung cancer	1.32e-05	0.000203	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—lung cancer	1.31e-05	0.000203	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—lung cancer	1.31e-05	0.000202	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—lung cancer	1.31e-05	0.000202	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—lung cancer	1.3e-05	0.000201	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—lung cancer	1.3e-05	0.0002	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—lung cancer	1.28e-05	0.000198	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—lung cancer	1.28e-05	0.000197	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—lung cancer	1.28e-05	0.000197	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—lung cancer	1.28e-05	0.000197	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—lung cancer	1.27e-05	0.000196	CcSEcCtD
Zalcitabine—Diarrhoea—Docetaxel—lung cancer	1.27e-05	0.000196	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—lung cancer	1.26e-05	0.000194	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—lung cancer	1.25e-05	0.000193	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—lung cancer	1.24e-05	0.000191	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—lung cancer	1.23e-05	0.00019	CcSEcCtD
Zalcitabine—Dizziness—Docetaxel—lung cancer	1.23e-05	0.00019	CcSEcCtD
Zalcitabine—Hypertension—Doxorubicin—lung cancer	1.23e-05	0.000189	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—lung cancer	1.22e-05	0.000188	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—lung cancer	1.21e-05	0.000187	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—lung cancer	1.21e-05	0.000187	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—lung cancer	1.21e-05	0.000187	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—lung cancer	1.21e-05	0.000186	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—lung cancer	1.2e-05	0.000184	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—lung cancer	1.19e-05	0.000184	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—lung cancer	1.19e-05	0.000184	CcSEcCtD
Zalcitabine—Dry mouth—Doxorubicin—lung cancer	1.18e-05	0.000183	CcSEcCtD
Zalcitabine—Vomiting—Docetaxel—lung cancer	1.18e-05	0.000182	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—lung cancer	1.18e-05	0.000182	CcSEcCtD
Zalcitabine—Rash—Docetaxel—lung cancer	1.17e-05	0.000181	CcSEcCtD
Zalcitabine—Dermatitis—Docetaxel—lung cancer	1.17e-05	0.000181	CcSEcCtD
Zalcitabine—Confusional state—Doxorubicin—lung cancer	1.17e-05	0.00018	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—lung cancer	1.17e-05	0.00018	CcSEcCtD
Zalcitabine—Headache—Docetaxel—lung cancer	1.16e-05	0.00018	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—lung cancer	1.16e-05	0.000179	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—lung cancer	1.16e-05	0.000178	CcSEcCtD
Zalcitabine—Infection—Doxorubicin—lung cancer	1.15e-05	0.000178	CcSEcCtD
Zalcitabine—Pain—Methotrexate—lung cancer	1.15e-05	0.000177	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—lung cancer	1.14e-05	0.000176	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—lung cancer	1.14e-05	0.000175	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—lung cancer	1.13e-05	0.000175	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—lung cancer	1.13e-05	0.000174	CcSEcCtD
Zalcitabine—Hyperhidrosis—Doxorubicin—lung cancer	1.12e-05	0.000173	CcSEcCtD
Zalcitabine—Anorexia—Doxorubicin—lung cancer	1.11e-05	0.000171	CcSEcCtD
Zalcitabine—Feeling abnormal—Methotrexate—lung cancer	1.1e-05	0.00017	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—lung cancer	1.1e-05	0.000169	CcSEcCtD
Zalcitabine—Urticaria—Methotrexate—lung cancer	1.06e-05	0.000164	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—lung cancer	1.06e-05	0.000163	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—lung cancer	1.06e-05	0.000163	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.06e-05	0.000163	CcSEcCtD
Zalcitabine—Insomnia—Doxorubicin—lung cancer	1.05e-05	0.000162	CcSEcCtD
Zalcitabine—Dyspnoea—Doxorubicin—lung cancer	1.03e-05	0.00016	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—lung cancer	1.03e-05	0.000159	CcSEcCtD
Zalcitabine—Dyspepsia—Doxorubicin—lung cancer	1.02e-05	0.000158	CcSEcCtD
Zalcitabine—Decreased appetite—Doxorubicin—lung cancer	1.01e-05	0.000156	CcSEcCtD
Zalcitabine—Fatigue—Doxorubicin—lung cancer	1e-05	0.000154	CcSEcCtD
Zalcitabine—Pain—Doxorubicin—lung cancer	9.92e-06	0.000153	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—lung cancer	9.87e-06	0.000152	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—lung cancer	9.62e-06	0.000148	CcSEcCtD
Zalcitabine—Feeling abnormal—Doxorubicin—lung cancer	9.56e-06	0.000147	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Doxorubicin—lung cancer	9.49e-06	0.000146	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—lung cancer	9.48e-06	0.000146	CcSEcCtD
Zalcitabine—Urticaria—Doxorubicin—lung cancer	9.22e-06	0.000142	CcSEcCtD
Zalcitabine—Abdominal pain—Doxorubicin—lung cancer	9.17e-06	0.000141	CcSEcCtD
Zalcitabine—Body temperature increased—Doxorubicin—lung cancer	9.17e-06	0.000141	CcSEcCtD
Zalcitabine—Diarrhoea—Methotrexate—lung cancer	9.17e-06	0.000141	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—lung cancer	8.86e-06	0.000137	CcSEcCtD
Zalcitabine—Hypersensitivity—Doxorubicin—lung cancer	8.55e-06	0.000132	CcSEcCtD
Zalcitabine—Vomiting—Methotrexate—lung cancer	8.52e-06	0.000131	CcSEcCtD
Zalcitabine—Rash—Methotrexate—lung cancer	8.45e-06	0.00013	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—lung cancer	8.44e-06	0.00013	CcSEcCtD
Zalcitabine—Headache—Methotrexate—lung cancer	8.4e-06	0.000129	CcSEcCtD
Zalcitabine—Asthenia—Doxorubicin—lung cancer	8.33e-06	0.000128	CcSEcCtD
Zalcitabine—Pruritus—Doxorubicin—lung cancer	8.21e-06	0.000127	CcSEcCtD
Zalcitabine—Diarrhoea—Doxorubicin—lung cancer	7.94e-06	0.000122	CcSEcCtD
Zalcitabine—Dizziness—Doxorubicin—lung cancer	7.67e-06	0.000118	CcSEcCtD
Zalcitabine—Vomiting—Doxorubicin—lung cancer	7.38e-06	0.000114	CcSEcCtD
Zalcitabine—Rash—Doxorubicin—lung cancer	7.32e-06	0.000113	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—lung cancer	7.31e-06	0.000113	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—lung cancer	7.27e-06	0.000112	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—ENO2—lung cancer	4.62e-06	0.000153	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HPGDS—lung cancer	4.62e-06	0.000153	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—B4GALT5—lung cancer	4.62e-06	0.000153	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CKB—lung cancer	4.61e-06	0.000153	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPP2R1B—lung cancer	4.59e-06	0.000152	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CKB—lung cancer	4.57e-06	0.000152	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—lung cancer	4.56e-06	0.000152	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTA4—lung cancer	4.49e-06	0.000149	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTT1—lung cancer	4.48e-06	0.000149	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GCLC—lung cancer	4.43e-06	0.000147	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2A6—lung cancer	4.43e-06	0.000147	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTA2—lung cancer	4.38e-06	0.000145	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CNDP2—lung cancer	4.33e-06	0.000144	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM2—lung cancer	4.33e-06	0.000144	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM2—lung cancer	4.3e-06	0.000143	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CNDP2—lung cancer	4.3e-06	0.000143	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	4.25e-06	0.000141	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTA1—lung cancer	4.22e-06	0.00014	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTMR3—lung cancer	4.21e-06	0.00014	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ENO1—lung cancer	4.2e-06	0.000139	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTMR3—lung cancer	4.18e-06	0.000139	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCC3—lung cancer	4.18e-06	0.000139	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PGAM1—lung cancer	4.11e-06	0.000136	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CB—lung cancer	4.09e-06	0.000136	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PGAM1—lung cancer	4.07e-06	0.000135	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—lung cancer	4.06e-06	0.000135	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKR1C1—lung cancer	4.04e-06	0.000134	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CB—lung cancer	4.03e-06	0.000134	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—lung cancer	3.99e-06	0.000133	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ATP5H—lung cancer	3.98e-06	0.000132	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—POMC—lung cancer	3.96e-06	0.000132	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—UGT1A1—lung cancer	3.93e-06	0.00013	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2A7—lung cancer	3.92e-06	0.00013	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2A7—lung cancer	3.88e-06	0.000129	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SDC4—lung cancer	3.83e-06	0.000127	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SDC4—lung cancer	3.8e-06	0.000126	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GNG11—lung cancer	3.79e-06	0.000126	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2E1—lung cancer	3.76e-06	0.000125	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NQO1—lung cancer	3.72e-06	0.000124	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALDOA—lung cancer	3.6e-06	0.00012	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLBD1—lung cancer	3.54e-06	0.000118	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTEN—lung cancer	3.54e-06	0.000117	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NCOA3—lung cancer	3.5e-06	0.000116	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—RRM1—lung cancer	3.49e-06	0.000116	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA3—lung cancer	3.49e-06	0.000116	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTEN—lung cancer	3.48e-06	0.000116	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA3—lung cancer	3.46e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—RRM1—lung cancer	3.46e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADCY1—lung cancer	3.4e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCG2—lung cancer	3.4e-06	0.000113	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—EP300—lung cancer	3.37e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—STK11—lung cancer	3.36e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ENO2—lung cancer	3.34e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HPGDS—lung cancer	3.34e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—EP300—lung cancer	3.32e-06	0.00011	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPP2R1B—lung cancer	3.32e-06	0.00011	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—B4GALT5—lung cancer	3.28e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—B4GALT5—lung cancer	3.26e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD17B10—lung cancer	3.24e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTT1—lung cancer	3.24e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2A6—lung cancer	3.2e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GCLC—lung cancer	3.2e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA4—lung cancer	3.19e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA4—lung cancer	3.17e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA2—lung cancer	3.11e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTP1—lung cancer	3.1e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.09e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA2—lung cancer	3.09e-06	0.000102	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ENO1—lung cancer	3.03e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CAT—lung cancer	3.02e-06	0.0001	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CKB—lung cancer	3.01e-06	0.0001	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA1—lung cancer	3e-06	9.97e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA1—lung cancer	2.98e-06	9.89e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCC3—lung cancer	2.97e-06	9.86e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCC3—lung cancer	2.94e-06	9.77e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCB1—lung cancer	2.94e-06	9.76e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TYMS—lung cancer	2.89e-06	9.58e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKR1C1—lung cancer	2.88e-06	9.55e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—lung cancer	2.85e-06	9.47e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKR1C1—lung cancer	2.85e-06	9.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM2—lung cancer	2.83e-06	9.41e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CNDP2—lung cancer	2.83e-06	9.41e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—UGT1A1—lung cancer	2.79e-06	9.27e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—UGT1A1—lung cancer	2.77e-06	9.19e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTMR3—lung cancer	2.76e-06	9.15e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2E1—lung cancer	2.72e-06	9.04e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1A1—lung cancer	2.7e-06	8.98e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GNG11—lung cancer	2.69e-06	8.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NQO1—lung cancer	2.69e-06	8.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PGAM1—lung cancer	2.69e-06	8.92e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ERCC2—lung cancer	2.68e-06	8.91e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GNG11—lung cancer	2.67e-06	8.86e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.66e-06	8.82e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALDOA—lung cancer	2.56e-06	8.51e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2A7—lung cancer	2.56e-06	8.51e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALDOA—lung cancer	2.54e-06	8.44e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SDC4—lung cancer	2.51e-06	8.32e-05	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—lung cancer	2.49e-06	8.28e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOA3—lung cancer	2.49e-06	8.26e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOA3—lung cancer	2.47e-06	8.19e-05	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—lung cancer	2.46e-06	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—STK11—lung cancer	2.43e-06	8.05e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.42e-06	8.05e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADCY1—lung cancer	2.42e-06	8.04e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCG2—lung cancer	2.42e-06	8.04e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCG2—lung cancer	2.4e-06	7.97e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADCY1—lung cancer	2.4e-06	7.97e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HPGDS—lung cancer	2.37e-06	7.88e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ENO2—lung cancer	2.37e-06	7.88e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.36e-06	7.83e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HPGDS—lung cancer	2.35e-06	7.81e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ENO2—lung cancer	2.35e-06	7.81e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPP2R1B—lung cancer	2.34e-06	7.77e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOA1—lung cancer	2.32e-06	7.71e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.31e-06	7.66e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTT1—lung cancer	2.3e-06	7.65e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—RRM1—lung cancer	2.28e-06	7.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA3—lung cancer	2.28e-06	7.58e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTT1—lung cancer	2.28e-06	7.58e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2A6—lung cancer	2.28e-06	7.56e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GCLC—lung cancer	2.28e-06	7.56e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GCLC—lung cancer	2.26e-06	7.49e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2A6—lung cancer	2.26e-06	7.49e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.25e-06	7.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTP1—lung cancer	2.24e-06	7.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CAT—lung cancer	2.18e-06	7.25e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ENO1—lung cancer	2.16e-06	7.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—B4GALT5—lung cancer	2.15e-06	7.13e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ENO1—lung cancer	2.14e-06	7.1e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.13e-06	7.08e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCB1—lung cancer	2.12e-06	7.05e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CG—lung cancer	2.12e-06	7.03e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.1e-06	6.99e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA4—lung cancer	2.09e-06	6.93e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TYMS—lung cancer	2.09e-06	6.93e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—lung cancer	2.06e-06	6.85e-05	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—lung cancer	2.04e-06	6.77e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA2—lung cancer	2.04e-06	6.76e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—POMC—lung cancer	2.02e-06	6.7e-05	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—lung cancer	2.01e-06	6.66e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CREBBP—lung cancer	1.96e-06	6.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA1—lung cancer	1.96e-06	6.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1A1—lung cancer	1.96e-06	6.49e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCC3—lung cancer	1.94e-06	6.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ERCC2—lung cancer	1.94e-06	6.44e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.94e-06	6.43e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2E1—lung cancer	1.92e-06	6.37e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NQO1—lung cancer	1.91e-06	6.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NQO1—lung cancer	1.9e-06	6.3e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.88e-06	6.24e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CD—lung cancer	1.86e-06	6.18e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.86e-06	6.17e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.84e-06	6.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—lung cancer	1.84e-06	6.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.83e-06	6.06e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GNG11—lung cancer	1.76e-06	5.84e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—STK11—lung cancer	1.72e-06	5.73e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—STK11—lung cancer	1.71e-06	5.68e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOA1—lung cancer	1.68e-06	5.57e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALDOA—lung cancer	1.68e-06	5.56e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOA3—lung cancer	1.63e-06	5.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CB—lung cancer	1.62e-06	5.39e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—lung cancer	1.61e-06	5.34e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.61e-06	5.33e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTP1—lung cancer	1.6e-06	5.3e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADCY1—lung cancer	1.58e-06	5.26e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCG2—lung cancer	1.58e-06	5.26e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTP1—lung cancer	1.58e-06	5.25e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CAT—lung cancer	1.55e-06	5.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HPGDS—lung cancer	1.55e-06	5.15e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ENO2—lung cancer	1.55e-06	5.15e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.54e-06	5.12e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CAT—lung cancer	1.54e-06	5.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CG—lung cancer	1.53e-06	5.09e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.53e-06	5.08e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCB1—lung cancer	1.51e-06	5.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTT1—lung cancer	1.51e-06	5e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCB1—lung cancer	1.5e-06	4.97e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCLC—lung cancer	1.49e-06	4.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.49e-06	4.94e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TYMS—lung cancer	1.48e-06	4.93e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TYMS—lung cancer	1.47e-06	4.88e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—lung cancer	1.47e-06	4.87e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—POMC—lung cancer	1.46e-06	4.84e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—lung cancer	1.45e-06	4.83e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CREBBP—lung cancer	1.42e-06	4.71e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ENO1—lung cancer	1.41e-06	4.68e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTEN—lung cancer	1.4e-06	4.66e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.39e-06	4.62e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ERCC2—lung cancer	1.38e-06	4.58e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1A1—lung cancer	1.38e-06	4.58e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ERCC2—lung cancer	1.37e-06	4.54e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CD—lung cancer	1.35e-06	4.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—EP300—lung cancer	1.34e-06	4.44e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—lung cancer	1.33e-06	4.41e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.27e-06	4.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NQO1—lung cancer	1.25e-06	4.15e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOA1—lung cancer	1.19e-06	3.96e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOA1—lung cancer	1.18e-06	3.93e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CB—lung cancer	1.17e-06	3.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—lung cancer	1.16e-06	3.86e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.13e-06	3.76e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—STK11—lung cancer	1.13e-06	3.74e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.09e-06	3.62e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CG—lung cancer	1.08e-06	3.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTP1—lung cancer	1.04e-06	3.46e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—POMC—lung cancer	1.04e-06	3.44e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—POMC—lung cancer	1.03e-06	3.41e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CAT—lung cancer	1.02e-06	3.37e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTEN—lung cancer	1.01e-06	3.37e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CREBBP—lung cancer	1.01e-06	3.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CREBBP—lung cancer	1e-06	3.32e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—lung cancer	9.9e-07	3.29e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCB1—lung cancer	9.88e-07	3.28e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TYMS—lung cancer	9.7e-07	3.22e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—EP300—lung cancer	9.67e-07	3.21e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—lung cancer	9.59e-07	3.18e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CD—lung cancer	9.57e-07	3.18e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CD—lung cancer	9.49e-07	3.15e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—lung cancer	9.45e-07	3.14e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—lung cancer	9.37e-07	3.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1A1—lung cancer	9.09e-07	3.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ERCC2—lung cancer	9.02e-07	2.99e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CB—lung cancer	8.34e-07	2.77e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CB—lung cancer	8.27e-07	2.75e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—lung cancer	8.27e-07	2.75e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—lung cancer	8.2e-07	2.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—lung cancer	8.08e-07	2.68e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOA1—lung cancer	7.8e-07	2.59e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTEN—lung cancer	7.21e-07	2.39e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—lung cancer	7.15e-07	2.38e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTEN—lung cancer	7.15e-07	2.37e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CG—lung cancer	7.12e-07	2.36e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—EP300—lung cancer	6.88e-07	2.28e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—EP300—lung cancer	6.82e-07	2.26e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—POMC—lung cancer	6.78e-07	2.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CREBBP—lung cancer	6.6e-07	2.19e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CD—lung cancer	6.26e-07	2.08e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—lung cancer	6.18e-07	2.05e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—lung cancer	5.84e-07	1.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CB—lung cancer	5.46e-07	1.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—lung cancer	5.41e-07	1.79e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—lung cancer	5.09e-07	1.69e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—lung cancer	5.04e-07	1.67e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTEN—lung cancer	4.71e-07	1.57e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—EP300—lung cancer	4.5e-07	1.49e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—lung cancer	4.16e-07	1.38e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—lung cancer	4.12e-07	1.37e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—lung cancer	3.33e-07	1.1e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—lung cancer	2.72e-07	9.02e-06	CbGpPWpGaD
